T1	PROC 1 28	Estudio clínico de eficacia
#1	AnnotatorNotes T1	C1707887; Efficacy Study; Research Activity + C0008976; Clinical Trials; Research Activity
T2	DISO 41 57	efectos adversos
#2	AnnotatorNotes T2	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T3	CHEM 74 91	ácido hialurónico
#3	AnnotatorNotes T3	C0020196; hyaluronic acid; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T4	ANAT 95 118	área buco-maxilo-facial
T5	PROC 120 190	Ensayo Clínico observacional y descriptivo, longitudinal y prospectivo
T6	PROC 276 292	Valorar eficacia
#4	AnnotatorNotes T6	C1707887; Efficacy Study; Research Activity
T7	DISO 305 321	efectos adversos
#5	AnnotatorNotes T7	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T8	CHEM 338 355	Ácido Hialurónico
#6	AnnotatorNotes T8	C0020196; hyaluronic acid; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T9	ANAT 375 394	surcos nasolabiales
#7	AnnotatorNotes T9	C0221328; Nasolabial sulcus; Body Location or Region | C0226931; Philtrum; Body Location or Region
T10	PROC 416 430	Ensayo clínico
#8	AnnotatorNotes T10	C0008976; Clinical Trials; Research Activity
T11	PROC 435 447	implantación
#9	AnnotatorNotes T11	C0021107; Implantation procedure; Therapeutic or Preventive Procedure
T12	ANAT 461 473	dermis media
T13	PROC 564 594	registros clínico-fotográficos
T14	DISO 826 842	Efectos adversos
#10	AnnotatorNotes T14	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T15	CHEM 930 932	AH
#11	AnnotatorNotes T15	C0020196; hyaluronic acid; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T16	ANAT 952 959	dérmico
#12	AnnotatorNotes T16	C0011646; Dermis; Tissue | C1284120; Entire dermis; Tissue
T17	DISO 1071 1090	REACCIONES ADVERSAS
#13	AnnotatorNotes T17	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T18	PROC 62 70	implante
#14	AnnotatorNotes T18	C0021107; Implantation procedure; Therapeutic or Preventive Procedure
T19	PROC 326 334	implante
#15	AnnotatorNotes T19	C0021107; Implantation procedure; Therapeutic or Preventive Procedure
T20	CHEM 357 360	A.H
#16	AnnotatorNotes T20	C0020196; hyaluronic acid; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T21	CHEM 451 454	A.H
#17	AnnotatorNotes T21	C0020196; hyaluronic acid; Organic Chemical · Pharmacologic Substance · Biologically Active Substance
T23	Duration 194 202	22 meses
T24	LIVB 222 231	pacientes
#18	AnnotatorNotes T24	C0030705; Patients; Patient or Disabled Group
T27	Duration 635 643	12 meses
T28	Duration 814 824	10,5 meses
T29	LIVB 884 893	pacientes
#19	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	Route 933 959	inyectable a nivel dérmico
#20	AnnotatorNotes T30	C1522447; Cutaneous Route of Drug Administration; Functional Concept
T31	Duration 1033 1043	10,5 meses
T22	Date 609 630	pre y post-aplicación
T25	Neg_cue 856 860	cero
T26	Neg_cue 1092 1096	cero
A1	Assertion T14 Negated
A2	Assertion T17 Negated
R1	Causes Arg1:T18 Arg2:T2	
R2	Used_for Arg1:T3 Arg2:T18	
R3	Location_of Arg1:T4 Arg2:T18	
R4	Has_Duration_or_Interval Arg1:T5 Arg2:T23	
R5	Causes Arg1:T19 Arg2:T7	
R6	Used_for Arg1:T8 Arg2:T19	
R7	Used_for Arg1:T20 Arg2:T19	
R8	Location_of Arg1:T9 Arg2:T19	
R9	Used_for Arg1:T21 Arg2:T11	
R10	Location_of Arg1:T12 Arg2:T11	
R11	Overlap Arg1:T13 Arg2:T22	
R12	Has_Duration_or_Interval Arg1:T13 Arg2:T27	
T32	CONC 659 671	escalas WSRS
T33	CONC 673 677	GAIS
T34	CONC 680 684	PSSS
T35	Result_or_Value 491 503	grado 2 al 5
T36	CONC 510 533	escala diagnóstica WSRS
R13	Has_Result_or_Value Arg1:T36 Arg2:T35	
R14	Negation Arg1:T25 Arg2:T14	
R15	Has_Route_or_Mode Arg1:T15 Arg2:T30	
R16	Negation Arg1:T26 Arg2:T17	
#21	AnnotatorNotes T32	[Wrinkle Severity Rating Scale]
#22	AnnotatorNotes T36	[Wrinkle Severity Rating Scale]
#23	AnnotatorNotes T33	[Global Aesthetic Improvement Scale]
#24	AnnotatorNotes T4	C4037961; Maxillofacial region; Body Location or Region + C0230028; Oral region; Body Location or Region | C1284858; Entire oral region of face; Body Location or Region
T37	CONC 781 789	Duración
#25	AnnotatorNotes T37	C0449238; Duration (temporal concept); Temporal Concept
R17	Has_Duration_or_Interval Arg1:T37 Arg2:T28	
T38	Quantifier_or_Qualifier 804 812	efectiva
#26	AnnotatorNotes T38	C1704419; Effective; Qualitative Concept
R18	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T38	
T39	CONC 1015 1023	DURACION
#27	AnnotatorNotes T39	C0449238; Duration (temporal concept); Temporal Concept
R19	Has_Duration_or_Interval Arg1:T39 Arg2:T31	
A3	Experiencer T29 Patient
A4	Experiencer T24 Patient
